Literature DB >> 26052800

TAFRO syndrome: 2 cases and review of the literature.

Mikako Kawashima1, Taro Usui1, Hideyuki Okada1, Ichiro Mori1, Masahiro Yamauchi1, Takahide Ikeda1, Kazuo Kajita1, Yusuke Kito2, Tatsuhiko Miyazaki2, Kei Fujioka3, Tatsuo Ishizuka3, Hiroyuki Morita1.   

Abstract

Recently, more than ten cases of thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome or Castleman-Kojima disease exhibiting such symptoms as thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly have been reported in Japan. We have found two cases of TAFRO syndrome and have reviewed another eighteen previously reported cases. Histological findings of the lymph nodes and levels of interleukin 6 (IL-6) and vascular endothelial growth factor in both serum/plasma and effusions are important characteristics for diagnosing this syndrome.

Entities:  

Keywords:  Anasarca; Fever; Organomegaly; Reticulin fibrosis; Thrombocytopenia

Mesh：

Substances：

Year:  2015        PMID： 26052800     DOI： 10.3109/14397595.2015.1059982

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN： 1439-7595            Impact factor:   3.023


  17 in total

1.  Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.

Authors:  Hirotaka Saito; Kenichi Tanaka; Momoko Fujiwara; Tsuyoshi Iwasaki; Tokutaro Numata; Akira Oda; Makoto Kanno; Mizuko Tanaka; Masaaki Eiro; Mamoru Satoh; Junichiro James Kazama
Journal:  CEN Case Rep       Date:  2019-05-10

2.  Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman's disease.

Authors:  Alvaro Ortiz; Pedro Cárdenas; Marcela Peralta; Harold Rodríguez; Gabriel Frederick; Jacobo Ortiz
Journal:  Int Ophthalmol       Date:  2017-07-27       Impact factor: 2.029

3.  Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.

Authors:  Sylvain Raoul Simeni Njonnou; Justine Deuson; Claire Royer-Chardon; Frédéric Alain Vandergheynst; Virginie De Wilde
Journal:  BMJ Case Rep       Date:  2020-06-30

Review 4.  Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.

Authors:  Taku Kikuchi; Takayuki Shimizu; Takaaki Toyama; Ryohei Abe; Shinichiro Okamoto
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

5.  Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.

Authors:  Mizuho Nara; Atsushi Komatsuda; Fumiko Itoh; Hajime Kaga; Masaya Saitoh; Masaru Togashi; Yoshihiro Kameoka; Hideki Wakui; Naoto Takahashi
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

6.  A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.

Authors:  Fabio Freire José; Lucila Nassif Kerbauy; Guilherme Fleury Perini; Danielle Isadora Blumenschein; Denise da Cunha Pasqualin; Denise Maria Avancini Costa Malheiros; Guilherme de Carvalho Campos Neto; Fabio Pires de Souza Santos; Ronaldo Piovesan; Nelson Hamerschlak
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Serial Manifestation of Acute Kidney Injury and Nephrotic Syndrome in a Patient with TAFRO Syndrome.

Authors:  Seigo Ito; Takahiro Uchida; Hiroki Itai; Aoi Yamashiro; Akira Yamagata; Hidehito Matsubara; Toshihiko Imakiire; Hideyuki Shimazaki; Hiroo Kumagai; Naoki Oshima
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

8.  Complete Resolution of a Case of TAFRO Syndrome Accompanied by Mediastinal Panniculitis, Adrenal Lesion, and Liver Damage with Hyperbilirubinemia.

Authors:  Shiro Ono; Kiyomi Yoshimoto; Nobushiro Nishimura; Ryo Yoneima; Hiromasa Kawashima; Tadanao Kobayashi; Yoshiaki Tai; Makiko Miyamoto; Emiko Tsushima; Noritaka Yada; Kenji Nishio
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

Review 9.  Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.

Authors:  Mari Tanaka; Hiraku Tsujimoto; Kojiro Yamamoto; Saeko Shimoda; Kazumasa Oka; Hiroya Takeoka
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

10.  Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.

Authors:  Yuhei Noda; Yosuke Saka; Akihisa Kato; Tetsushi Mimura; Tomohiko Naruse
Journal:  Clin Nephrol Case Stud       Date:  2018-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.